Atezolizumab
Product Specifications
CAS Number
1380723-44-3
Target
Apoptosis, Autophagy, PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Autophagy, Immunology/Inflammation, Apoptosis
Purity
0.993
Bioactivity
Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1 and blocks the interaction of PD-L1 with PD-1. Atezolizumab has antitumor activity and promotes T-cells to attack tumor cells.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2329408 1.0 µg DNA
TAF10 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
MBS2040309-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Cathepsin K (CTSK)
Sign In for Pricing
View Details MBS2040309-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Cathepsin K (CTSK)
Sign In for Pricing
View Details